Clinical Pharmacology of FYU-981 (Effect on QT/QTc Interval)

NCT02515864 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

48

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: FYU-981
DRUG: Placebo
DRUG: Moxifloxacin
DRUG: Moxifloxacin Placebo

Sponsor

Fuji Yakuhin Co., Ltd.